Chiesi is an international, research-oriented biopharmaceutical group that develops innovative therapeutic solutions for respiratory diseases, neonatology, specialty care (including inflammatory bowel disease) and rare diseases.
Chiesi has more than 85 years of experience in the pharmaceutical industry and employs more than 6,000 people worldwide. Chiesi is headquartered in Parma (Italy).
As a B-Corp certified family business, we meet the highest standards in both social and environmental impact. Chiesi therefore aims to reach net-zero by 2035.